Gerard Silvestri to Middle Aged
This is a "connection" page, showing publications Gerard Silvestri has written about Middle Aged.
Connection Strength
1.654
-
Lung Cancer Screening Eligibility and Screening Patterns Among Black and White Adults in the United States. JAMA Netw Open. 2021 10 01; 4(10):e2130350.
Score: 0.056
-
Knowledge and Practice Patterns Among Pulmonologists for Molecular Biomarker Testing in Advanced Non-small Cell Lung Cancer. Chest. 2021 12; 160(6):2293-2303.
Score: 0.055
-
Cancer Outcomes Among Medicare Beneficiaries And Their Younger Uninsured Counterparts. Health Aff (Millwood). 2021 05; 40(5):754-762.
Score: 0.054
-
Incorporating Baseline Lung Function in Lung Cancer Screening: Does a "Lung Health Check" Help Predict Outcomes? Chest. 2021 04; 159(4):1664-1669.
Score: 0.052
-
Occurrence of Discussion about Lung Cancer Screening Between Patients and Healthcare Providers in the USA, 2017. J Cancer Educ. 2020 08; 35(4):678-681.
Score: 0.051
-
Association of Cigarette Type and Nicotine Dependence in Patients Presenting for Lung Cancer Screening. Chest. 2020 11; 158(5):2184-2191.
Score: 0.051
-
Screening Adherence in the Veterans Administration Lung Cancer Screening Demonstration Project. Chest. 2020 10; 158(4):1742-1752.
Score: 0.051
-
An Evaluation of Diagnostic Yield From Bronchoscopy: The Impact of Clinical/Radiographic Factors, Procedure Type, and Degree of Suspicion for Cancer. Chest. 2020 06; 157(6):1656-1664.
Score: 0.049
-
Association of Cigarette Type With Lung Cancer Incidence and Mortality: Secondary Analysis of the National Lung Screening Trial. JAMA Intern Med. 2019 12 01; 179(12):1710-1712.
Score: 0.049
-
Standard Bronchoscopy With Fluoroscopy vs Thin Bronchoscopy and Radial Endobronchial Ultrasound for Biopsy of Pulmonary Lesions: A Multicenter, Prospective, Randomized Trial. Chest. 2018 11; 154(5):1035-1043.
Score: 0.045
-
A Patient-Centered Activity Regimen Improves Participation in Physical Activity Interventions in Advanced-Stage Lung Cancer. Integr Cancer Ther. 2018 09; 17(3):921-927.
Score: 0.044
-
Assessment of Plasma Proteomics Biomarker's Ability to Distinguish Benign From Malignant Lung Nodules: Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial. Chest. 2018 09; 154(3):491-500.
Score: 0.043
-
Physician Assessment of Pretest Probability of Malignancy and Adherence With Guidelines for Pulmonary Nodule Evaluation. Chest. 2017 08; 152(2):263-270.
Score: 0.040
-
Assessing the Correlation Between Physical Activity and Quality of Life in Advanced Lung Cancer. Integr Cancer Ther. 2018 03; 17(1):73-79.
Score: 0.040
-
The Association between Smoking Abstinence and Mortality in the National Lung Screening Trial. Am J Respir Crit Care Med. 2016 Mar 01; 193(5):534-41.
Score: 0.038
-
Management of Pulmonary Nodules by Community Pulmonologists: A Multicenter Observational Study. Chest. 2015 Dec; 148(6):1405-1414.
Score: 0.037
-
Racial Differences in Outcomes within the National Lung Screening Trial. Implications for Widespread Implementation. Am J Respir Crit Care Med. 2015 Jul 15; 192(2):200-8.
Score: 0.036
-
The effect of respiratory motion on pulmonary nodule location during electromagnetic navigation bronchoscopy. Chest. 2015 May; 147(5):1275-1281.
Score: 0.036
-
Lung cancer screening. Am J Respir Crit Care Med. 2015 Jan 01; 191(1):19-33.
Score: 0.035
-
Assessing the usefulness of 18F-fluorodeoxyglucose PET-CT scan after stereotactic body radiotherapy for early-stage non-small cell lung cancer. Chest. 2014 Aug; 146(2):406-411.
Score: 0.034
-
The utility of nodule volume in the context of malignancy prediction for small pulmonary nodules. Chest. 2014 Mar 01; 145(3):464-472.
Score: 0.033
-
Attitudes and beliefs toward lung cancer screening among US Veterans. Chest. 2013 Dec; 144(6):1783-1787.
Score: 0.032
-
Drusen prevalence and pigmentary changes in Caucasians aged 18-54 years. Eye (Lond). 2012 Oct; 26(10):1357-62.
Score: 0.030
-
Lung cancer screening practices of primary care physicians: results from a national survey. Ann Fam Med. 2012 Mar-Apr; 10(2):102-10.
Score: 0.029
-
Understanding the economic impact of introducing a new procedure: calculating downstream revenue of endobronchial ultrasound with transbronchial needle aspiration as a model. Chest. 2012 Feb; 141(2):506-512.
Score: 0.028
-
Screening for lung cancer: it works, but does it really work? Ann Intern Med. 2011 Oct 18; 155(8):537-9.
Score: 0.028
-
Using endobronchial ultrasound features to predict lymph node metastasis in patients with lung cancer. Chest. 2011 Dec; 140(6):1550-1556.
Score: 0.027
-
Barriers to hospice enrollment among lung cancer patients: a survey of family members and physicians. Palliat Support Care. 2008 Dec; 6(4):357-62.
Score: 0.023
-
A phase 3, randomized, double-blind study to assess the efficacy and safety of fospropofol disodium injection for moderate sedation in patients undergoing flexible bronchoscopy. Chest. 2009 Jan; 135(1):41-47.
Score: 0.022
-
Real-time endobronchial ultrasound-guided transbronchial lymph node aspiration. Ann Thorac Surg. 2008 Jan; 85(1):224-30.
Score: 0.021
-
A pilot study of narrow-band imaging compared to white light bronchoscopy for evaluation of normal airways and premalignant and malignant airways disease. Chest. 2007 Jun; 131(6):1794-9.
Score: 0.021
-
Attitudes towards screening for lung cancer among smokers and their non-smoking counterparts. Thorax. 2007 Feb; 62(2):126-30.
Score: 0.020
-
Intensive care decision making in the seriously ill and elderly. Crit Care Med. 2004 Mar; 32(3):649-54.
Score: 0.016
-
What happens to patients undergoing lung cancer surgery? Outcomes and quality of life before and after surgery. Chest. 2002 Jul; 122(1):21-30.
Score: 0.015
-
Predicted impact of attaining smoking reduction goals on mortality. South Med J. 2001 Feb; 94(2):176-83.
Score: 0.013
-
Performance of Risk Factor-Based Guidelines and Model-Based Chest CT Lung Cancer Screening in World Trade Center-Exposed Fire Department Rescue/Recovery Workers. Chest. 2021 05; 159(5):2060-2071.
Score: 0.013
-
First-in-Human Use of a Hybrid Real-Time Ultrasound-Guided Fine-Needle Acquisition System for Peripheral Pulmonary Lesions: A Multicenter Pilot Study. Respiration. 2019; 98(6):527-533.
Score: 0.012
-
Patient-Level Trajectories and Outcomes After Low-Dose CT Screening in the National Lung Screening Trial. Chest. 2019 11; 156(5):965-971.
Score: 0.012
-
Safety and diagnostic performance of pulmonologists performing electromagnetic guided percutaneous lung biopsy (SPiNperc). Respirology. 2019 05; 24(5):453-458.
Score: 0.012
-
Safety and Efficacy of Remimazolam Compared With Placebo and Midazolam for?Moderate Sedation During Bronchoscopy. Chest. 2019 01; 155(1):137-146.
Score: 0.011
-
Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews. BMJ. 1998 Sep 19; 317(7161):771-5.
Score: 0.011
-
Specialists achieve better outcomes than generalists for lung cancer surgery. Chest. 1998 Sep; 114(3):675-80.
Score: 0.011
-
Incorporating Coexisting Chronic Illness into Decisions about Patient Selection for Lung Cancer Screening. An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2018 07 15; 198(2):e3-e13.
Score: 0.011
-
Tobacco Dependence Predicts Higher Lung Cancer and Mortality Rates and Lower Rates of Smoking Cessation in the National Lung Screening Trial. Chest. 2018 07; 154(1):110-118.
Score: 0.011
-
Screening for Lung Cancer: CHEST Guideline and Expert Panel Report. Chest. 2018 04; 153(4):954-985.
Score: 0.011
-
Dietary Patterns and Retinal Vessel Caliber in the Irish Nun Eye Study. J Nutr Health Aging. 2018; 22(7):751-758.
Score: 0.011
-
Racial and Ethnic Disparities in Early-Stage Lung Cancer Survival. Chest. 2017 09; 152(3):587-597.
Score: 0.010
-
Primary Care Provider and Patient Perspectives on Lung Cancer Screening. A Qualitative Study. Ann Am Thorac Soc. 2016 11; 13(11):1977-1982.
Score: 0.010
-
Factors Associated with a Positive Baseline Screening Exam Result in the National Lung Screening Trial. Ann Am Thorac Soc. 2016 09; 13(9):1568-74.
Score: 0.010
-
Clinical Utility of a Bronchial Genomic Classifier in Patients With Suspected Lung Cancer. Chest. 2016 Jul; 150(1):210-8.
Score: 0.009
-
Lung cancer risk test trial: study design, participant baseline characteristics, bronchoscopy safety, and establishment of a biospecimen repository. BMC Pulm Med. 2016 Jan 22; 16:16.
Score: 0.009
-
Derivation of a bronchial genomic classifier for lung cancer in a prospective study of patients undergoing diagnostic bronchoscopy. BMC Med Genomics. 2015 May 06; 8:18.
Score: 0.009
-
Bronchoscopic transparenchymal nodule access (BTPNA): first in human trial of a novel procedure for sampling solitary pulmonary nodules. Thorax. 2015 Apr; 70(4):326-32.
Score: 0.009
-
Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts. PLoS Med. 2014 Dec; 11(12):e1001764.
Score: 0.009
-
Factors that influence physician decision making for indeterminate pulmonary nodules. Ann Am Thorac Soc. 2014 Dec; 11(10):1586-91.
Score: 0.009
-
Cost-effectiveness of CT screening in the National Lung Screening Trial. N Engl J Med. 2014 Nov 06; 371(19):1793-802.
Score: 0.009
-
Outcome of patients with negative and unsatisfactory cytologic specimens obtained by endobronchial ultrasound-guided transbronchial fine-needle aspiration of mediastinal lymph nodes. Cancer Cytopathol. 2015 Feb; 123(2):92-7.
Score: 0.009
-
Evaluating the effect of access to free medication to quit smoking: a clinical trial testing the role of motivation. Nicotine Tob Res. 2014 Jul; 16(7):992-9.
Score: 0.008
-
A new mtDNA mutation in the tRNA(Leu(UUR)) gene associated with maternally inherited cardiomyopathy. Hum Mutat. 1994; 3(1):37-43.
Score: 0.008
-
Evaluation of dyspnea in the elderly patient. Clin Chest Med. 1993 Sep; 14(3):393-404.
Score: 0.008
-
Targeting of low-dose CT screening according to the risk of lung-cancer death. N Engl J Med. 2013 Jul 18; 369(3):245-254.
Score: 0.008
-
Clinical features associated with the A-->G transition at nucleotide 8344 of mtDNA ("MERRF mutation"). Neurology. 1993 Jun; 43(6):1200-6.
Score: 0.008
-
Peripapillary subretinal neovascular membranes: the natural history. Eye (Lond). 1993; 7 ( Pt 3):398-402.
Score: 0.008
-
Acute retinal necrosis in the United Kingdom: results of a prospective surveillance study. Eye (Lond). 2012 Mar; 26(3):370-7; quiz 378.
Score: 0.007
-
Cigarette smoking and the risk of dying from tobacco-related malignancies by race. Anticancer Res. 2011 Nov; 31(11):3891-5.
Score: 0.007
-
High-dose fractionated radiotherapy to 80 Gy for stage I-II medically inoperable non-small-cell lung cancer. J Med Imaging Radiat Oncol. 2010 Dec; 54(6):554-61.
Score: 0.007
-
Mediastinal lymphadenopathy in patients undergoing cardiac transplant evaluation. Chest. 2011 Jun; 139(6):1451-1457.
Score: 0.007
-
Involved-field radiotherapy with concurrent chemotherapy for limited-stage small-cell lung cancer: disease control, patterns of failure and survival. J Med Imaging Radiat Oncol. 2010 Oct; 54(5):483-9.
Score: 0.006
-
Nurses' identification of important yet under-utilized end-of-life care skills for patients with life-limiting or terminal illnesses. J Palliat Med. 2010 Jun; 13(6):753-9.
Score: 0.006
-
Pseudophakic retinal detachments and post-operative visual acuity. Int Ophthalmol. 1989 Sep; 13(5):345-9.
Score: 0.006
-
The risk of dying from lung cancer by race: a prospective cohort study in a biracial cohort in Charleston, South Carolina. Ann Epidemiol. 2009 May; 19(5):304-10.
Score: 0.006
-
The association between multifocal electroretinograms and OCT retinal thickness in retinitis pigmentosa patients with good visual acuity. Eye (Lond). 2009 Jul; 23(7):1524-31.
Score: 0.006
-
Underuse of surgical resection for localized, non-small cell lung cancer among whites and African Americans in South Carolina. Ann Thorac Surg. 2008 Jul; 86(1):220-6; discussion 227.
Score: 0.006
-
Implicit and explicit aspects of sequence learning in pre-symptomatic Huntington's disease. Parkinsonism Relat Disord. 2008 Aug; 14(6):457-64.
Score: 0.005
-
Validation of two models to estimate the probability of malignancy in patients with solitary pulmonary nodules. Thorax. 2008 Apr; 63(4):335-41.
Score: 0.005
-
Endobronchial ultrasound for the diagnosis of pulmonary sarcoidosis. Chest. 2007 Oct; 132(4):1298-304.
Score: 0.005
-
Presumed infectious endophthalmitis following cataract surgery in the UK: a case-control study of risk factors. Eye (Lond). 2007 May; 21(5):580-6.
Score: 0.005
-
Conformal high dose external radiation therapy, 80.5 Gy, alone for medically inoperable non-small cell lung cancer: a retrospective analysis. J Thorac Oncol. 2006 Feb; 1(2):112-9.
Score: 0.005
-
Surveillance of endophthalmitis following cataract surgery in the UK. Eye (Lond). 2004 Jun; 18(6):580-7.
Score: 0.004
-
Accuracy of EUS criteria and primary tumor site for identification of mediastinal lymph node metastasis from non-small-cell lung cancer. Gastrointest Endosc. 2004 Feb; 59(2):205-12.
Score: 0.004
-
Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer. J Thorac Cardiovasc Surg. 2003 Dec; 126(6):1943-51.
Score: 0.004
-
Lunx is a superior molecular marker for detection of non-small cell lung cancer in peripheral blood [corrected]. J Mol Diagn. 2003 Nov; 5(4):237-42.
Score: 0.004
-
Racial differences pertaining to a belief about lung cancer surgery: results of a multicenter survey. Ann Intern Med. 2003 Oct 07; 139(7):558-63.
Score: 0.004
-
Effects of short-term, integrated body mass reduction program on maximal oxygen consumption and anaerobic alactic performance in obese subjects. Diabetes Nutr Metab. 2003 Feb; 16(1):24-31.
Score: 0.004
-
Pulmonary complications after esophagectomy. Ann Thorac Surg. 2002 Mar; 73(3):922-6.
Score: 0.004
-
Endoscopic ultrasound-guided fine needle aspiration for staging patients with carcinoma of the lung. Ann Thorac Surg. 2001 Dec; 72(6):1861-7.
Score: 0.004
-
Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA. Neuromuscul Disord. 1993 Jan; 3(1):43-50.
Score: 0.002
-
MELAS: clinical features, biochemistry, and molecular genetics. Ann Neurol. 1992 Apr; 31(4):391-8.
Score: 0.002
-
[Testosterone propionate in the treatment of hyperazotemic syndromes]. Clin Ter. 1966 Jul 15; 38(1):3-26.
Score: 0.001